Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor

Journal of Medicinal Chemistry
János T KodraJesper Lau

Abstract

Optimization of a new series of small molecule human glucagon receptor (hGluR) antagonists is described. In the process of optimizing glucagon receptor antagonists, we counter-screened against the closely related human gastric inhibitory polypeptide receptor (hGIPR), and through structure activity analysis, we obtained compounds with low nanomolar affinities toward the hGluR, which were selective against the hGIPR and the human glucagon-like peptide-1 receptor (hGLP-1R). In the best cases, we obtained a >50 fold selectivity for the hGluR over the hGIPR and a >1000 fold selectivity over the hGLP-1R. A potent and selective glucagon receptor antagonist was demonstrated to inhibit glucagon-induced glycogenolysis in primary rat hepatocytes as well as to lower glucagon-induced hyperglycemia in Sprague-Dawley rats. Furthermore, the compound was shown to lower blood glucose in the ob/ob mouse after oral dosing.

References

May 8, 1975·The New England Journal of Medicine·J E GerichP H Forsham
Mar 1, 1992·Diabetes Care·R A DeFronzoE Ferrannini
Jan 1, 1986·Diabetologia·M NauckW Creutzfeldt
Feb 9, 2000·Life Sciences·R G Yip, M M Wolfe
Jun 18, 2002·Nature Medicine·Kazumasa MiyawakiYutaka Seino
Apr 15, 2004·Bioorganic & Medicinal Chemistry Letters·Ravi KurukulasuriyaChristine A Collins
Jan 19, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J J Meier, M A Nauck
Aug 17, 2005·Bioorganic & Medicinal Chemistry Letters·Dong-Ming ShenEmma R Parmee
Jan 5, 2007·Journal of Medicinal Chemistry·Jesper LauPeter Madsen

❮ Previous
Next ❯

Citations

Jun 1, 2010·Journal of Computer-aided Molecular Design·Supriyo BhattacharyaNagarajan Vaidehi
May 1, 2009·Nature Reviews. Drug Discovery·Cyrus DeSouza, Vivian Fonseca
Oct 17, 2009·American Journal of Therapeutics·Zafar H Israili
Jun 14, 2012·Journal of Molecular Endocrinology·Run YuJános T Kodra
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
Jun 28, 2011·Lancet·Abd A TahraniAnthony H Barnett
Nov 26, 2009·Pharmacology & Therapeutics·Abd A TahraniAnthony H Barnett
Sep 14, 2010·British Journal of Clinical Pharmacology·Milan K PiyaAnthony H Barnett
Jun 4, 2011·Expert Opinion on Therapeutic Patents·Dong-Ming ShenEmma R Parmee
Dec 15, 2010·Bioorganic & Medicinal Chemistry Letters·Dong-Ming ShenEmma R Parmee
Mar 23, 2017·Endocrinology·Jens Juul HolstPedro L Herrera
Jun 28, 2016·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Nathan D TivendaleJerry D Cohen
Mar 13, 2012·Pharmacological Reviews·E J Verspohl
Mar 17, 2020·American Journal of Physiology. Gastrointestinal and Liver Physiology·Katrine D GalsgaardJens J Holst
Apr 8, 2020·American Journal of Physiology. Endocrinology and Metabolism·Katrine D GalsgaardJens J Holst
Oct 6, 2017·American Journal of Physiology. Endocrinology and Metabolism·Katrine D GalsgaardJens J Holst
Feb 13, 2015·The Open Medicinal Chemistry Journal·Mohamed LotfyErnest Adeghate
Feb 27, 2019·American Journal of Physiology. Endocrinology and Metabolism·Katrine D GalsgaardJens J Holst
Sep 17, 2020·Molecular Metabolism·Marie Winther-SørensenNicolai J Wewer Albrechtsen
Jul 18, 2020·Current Topics in Medicinal Chemistry·Worood Sirhan, Ron Piran
Aug 3, 2021·Journal of the Endocrine Society·Sasha A S KjeldsenNicolai J Wewer Albrechtsen
Jul 27, 2021·Chemical Biology & Drug Design·Chang-Yong LeeDongyun Shin
Apr 10, 2020·Current Diabetes Reviews·Deepshikha PatleGopal L Khatik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.